Quantitative estimates of motility from videocapsule endoscopy are useful to discern celiac patients from controls.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 22644741)

Published in Dig Dis Sci on May 30, 2012

Authors

Edward J Ciaccio1, Christina A Tennyson, Govind Bhagat, Suzanne K Lewis, Peter H Green

Author Affiliations

1: Department of Medicine, Celiac Disease Center, Columbia University, Harkness Pavilion 804, 180 Fort Washington Avenue, New York, NY 10032, USA. ciaccio@columbia.edu

Articles cited by this

Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med (1988) 2.27

Significance of unsuspected celiac disease detected at endoscopy. Gastrointest Endosc (2000) 2.18

The many faces of celiac disease: clinical presentation of celiac disease in the adult population. Gastroenterology (2005) 1.92

Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol (2007) 1.82

Gastroesophageal reflux symptoms in patients with celiac disease and the effects of a gluten-free diet. Clin Gastroenterol Hepatol (2010) 1.66

Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54

Classification and management of refractory coeliac disease. Gut (2010) 1.48

Distinguishing patients with celiac disease by quantitative analysis of videocapsule endoscopy images. Comput Methods Programs Biomed (2010) 1.17

Gastrointestinal motility disturbances in celiac disease. J Clin Gastroenterol (2004) 0.95

New insight into intestinal motor function via noninvasive endoluminal image analysis. Gastroenterology (2008) 0.92

Robust spectral analysis of videocapsule images acquired from celiac disease patients. Biomed Eng Online (2011) 0.89

Olympus capsule endoscopy for small bowel examination. J Gastrointestin Liver Dis (2007) 0.89

Classification of videocapsule endoscopy image patterns: comparative analysis between patients with celiac disease and normal individuals. Biomed Eng Online (2010) 0.89

Quantitative assessment of endoscopic images for degree of villous atrophy in celiac disease. Dig Dis Sci (2010) 0.86

Abnormal gastrointestinal motility in patients with celiac sprue. Dig Dis Sci (1994) 0.83

Findings in patients with chronic intestinal dysmotility investigated by capsule endoscopy. BMC Gastroenterol (2007) 0.83

Small intestinal motility. Curr Opin Gastroenterol (2008) 0.83

Quantitative assessment of the degree of villous atrophy in patients with coeliac disease. J Clin Pathol (2008) 0.82

Oesophageal motility in adult coeliac disease. Neurogastroenterol Motil (1995) 0.82

Telemetric small intestinal motility recording in awake rats: a novel approach. Eur Surg Res (2002) 0.79

Automatic detection of informative frames from wireless capsule endoscopy images. Med Image Anal (2010) 0.78

Intestinal motility assessment with video capsule endoscopy: automatic annotation of phasic intestinal contractions. IEEE Trans Med Imaging (2009) 0.78

Contraction detection in small bowel from an image sequence of wireless capsule endoscopy. Med Image Comput Comput Assist Interv (2007) 0.75

Articles by these authors

Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest (2003) 16.67

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature (2009) 7.37

Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55

Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet (2011) 6.06

The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell (2010) 4.71

Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell (2008) 4.43

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity (2004) 4.36

A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell (2007) 3.81

Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation. Science (2012) 3.24

Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol (2013) 3.13

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol (2013) 3.04

Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 3.00

AID is required for germinal center-derived lymphomagenesis. Nat Genet (2007) 2.79

IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity (2008) 2.78

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell (2010) 2.73

microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J Exp Med (2010) 2.68

Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature (2012) 2.64

EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell (2013) 2.63

The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood (2009) 2.36

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 2.30

Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med (2010) 2.30

Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell (2012) 2.16

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood (2012) 2.16

Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med (2006) 2.03

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell (2011) 2.01

Bibliometric study of the quality of celiac disease research publications. J Pediatr Gastroenterol Nutr (2013) 1.98

Risk of malignancy in patients with celiac disease. Am J Med (2003) 1.85

Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest Endosc (2010) 1.79

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Blood (2013) 1.72

Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood (2011) 1.72

Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med (2012) 1.66

Characteristics of patients who avoid wheat and/or gluten in the absence of Celiac disease. Dig Dis Sci (2013) 1.65

BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc Natl Acad Sci U S A (2009) 1.62

Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function. J Immunol (2010) 1.53

Prior endoscopy in patients with newly diagnosed celiac disease: a missed opportunity? Dig Dis Sci (2013) 1.53

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood (2013) 1.52

Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis. Leuk Lymphoma (2009) 1.51

FISH analysis in addition to G-band karyotyping: utility in evaluation of myelodysplastic syndromes? Leuk Res (2009) 1.50

EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc (2005) 1.45

The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies. Blood (2008) 1.45

Transient celiac autoimmunity in an adult. J Clin Gastroenterol (2011) 1.43

Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. J Clin Invest (2010) 1.40

Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes. Blood (2012) 1.38

TGFBI deficiency predisposes mice to spontaneous tumor development. Cancer Res (2009) 1.34

Prevalence of gluten-free diet adherence among individuals without celiac disease in the USA: results from the Continuous National Health and Nutrition Examination Survey 2009-2010. Scand J Gastroenterol (2013) 1.31

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood (2010) 1.27

IFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res (2011) 1.26

Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol (2007) 1.23

An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol (2009) 1.23

HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. Blood (2011) 1.22

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica (2012) 1.21

Overexpression of interleukin-1beta in the murine pancreas results in chronic pancreatitis. Gastroenterology (2008) 1.18

Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis (2005) 1.17

Association of intussusception and celiac disease in adults. Dig Dis Sci (2009) 1.17

Distinguishing patients with celiac disease by quantitative analysis of videocapsule endoscopy images. Comput Methods Programs Biomed (2010) 1.17

Sex and racial disparities in duodenal biopsy to evaluate for celiac disease. Gastrointest Endosc (2012) 1.15

Variability in small bowel histopathology reporting between different pathology practice settings: impact on the diagnosis of coeliac disease. J Clin Pathol (2011) 1.14

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries. Clin Cancer Res (2014) 1.13

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program. Cancer (2014) 1.13

IRF4 and its regulators: evolving insights into the pathogenesis of inflammatory arthritis? Immunol Rev (2010) 1.12

Extraintestinal manifestations of celiac disease. Curr Gastroenterol Rep (2006) 1.10

Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma. Hum Pathol (2013) 1.09

Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma (2009) 1.09

Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis. Mod Pathol (2005) 1.08

The pattern of cytoplasmic IgM expression in the context of the three currently recognised maturational stages of hematogones. Leuk Lymphoma (2009) 1.07

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood (2013) 1.06

Collagenous sprue is not always associated with dismal outcomes: a clinicopathological study of 19 patients. Mod Pathol (2009) 1.06

Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells. Proc Natl Acad Sci U S A (2009) 1.05

Anemia in celiac disease is multifactorial in etiology. Am J Hematol (2007) 1.04

An update on celiac disease histopathology and the road ahead. Arch Pathol Lab Med (2012) 1.03

Chronic hepatitis C virus and celiac disease, is there an association? Dig Dis Sci (2007) 1.03

Histopathology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.01

Increased incidence of eosinophilic esophagitis in children and adults with celiac disease. J Clin Gastroenterol (2012) 1.01

Progenitor cell expansion: an important source of hepatocyte regeneration in chronic hepatitis. J Hepatol (2004) 1.00

Hematogones: a review and update. Leuk Lymphoma (2010) 0.99

Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol (2010) 0.99

Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids. Am J Clin Pathol (2005) 0.98

Early T-cell precursor leukemia/lymphoma in adults and children. Leuk Res (2013) 0.97

Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol (2006) 0.97

Esophagitis dissecans superficialis. Gastrointest Endosc (2011) 0.96

Comparison of commercially available serologic kits for the detection of celiac disease. J Clin Gastroenterol (2009) 0.95

Congenital MLL-positive B-cell acute lymphoblastic leukemia (B-ALL) switched lineage at relapse to acute myelocytic leukemia (AML) with persistent t(4;11) and t(1;6) translocations and JH gene rearrangement. Leuk Lymphoma (2005) 0.95

Celiac disease in African-Americans. Dig Dis Sci (2006) 0.95

Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma. Clin Lymphoma Myeloma Leuk (2010) 0.95